BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation.

被引：0
|
作者：
Ko, Kichul [1 ]
Yanez, Denisse [1 ]
Kaverina, Natalya [1 ]
Liarski, Vladimir M. [1 ]
Peng, Yahui [2 ]
Lan, Li [1 ]
Perper, Stuart [3 ]
Schwartz, Annette [3 ]
O'connor, Liz [3 ]
Souers, Andrew [4 ]
Elmore, Steven [4 ]
Olson, Lisa [3 ]
Giger, Maryellen L. [1 ]
Wang, Li Chun [3 ]
Clark, Marcus R. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Beijing Jiaotong Univ, Beijing, Peoples R China
[3] AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
[4] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2839
引用
收藏
页码：S1241 / S1241
页数：1
相关论文
共 50 条
  • [21] Bcl-2 as target for anticancer therapies
    Pellecchia, M
    ANNALS OF ONCOLOGY, 2006, 17 : 23 - 23
  • [22] BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
    Yin, Jiawei
    Xie, Xiaoli
    Ye, Yufu
    Wang, Lijuan
    Che, Fengyuan
    BIOSCIENCE REPORTS, 2019, 39
  • [23] Ribonucleotide reductase subunit M2 regulates Bcl-2 in human cancer: A potential target for cancer therapy
    Rahman, Mohammad Aminur
    Amin, A. R. M. R.
    Koenig, Lydia
    Nannapaneni, Sreenivas
    Chen, Zhuo G.
    Shin, Dong M.
    CANCER RESEARCH, 2012, 72
  • [24] Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review
    Jagani, Hitesh
    Kasinathan, Narayanan
    Meka, Sreenivasa Reddy
    Josyula, Venkata Rao
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (05) : 1212 - 1221
  • [25] Discovery and therapeutic potential of novel Bcl-2/Bcl-xL small-molecule inhibitors in human breast cancer.
    Xu, L
    Wang, G
    Tang, N
    Nikolovska-Coleska, Z
    Wang, R
    Demchik, L
    Liu, M
    Zhang, M
    Roller, P
    Tomita, Y
    Yang, D
    Rae, J
    Lippman, ME
    Wang, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S66 - S66
  • [26] Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
    Diaz-Flores, Ernesto
    Comeaux, Evan Q.
    Kim, Kailyn L.
    Melnik, Ella
    Beckman, Kyle
    Davis, Kara L.
    Wu, Kevin
    Akutagawa, Jon
    Bridges, Olga
    Marino, Roberta
    Wohlfeil, Margo
    Braun, Benjamin S.
    Mullighan, Charles G.
    Loh, Mignon L.
    CANCER RESEARCH, 2019, 79 (09) : 2339 - 2351
  • [27] Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with gastric carcinoma.
    Kim, R
    Emi, M
    Tanabe, K
    Toge, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 320S - 320S
  • [28] Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with breast cancer.
    Kim, R
    Emi, M
    Tanabe, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S284 - S284
  • [29] BCL-2: A New Therapeutic Target in Estrogen Receptor-Positive Breast Cancer?
    Martin, Lesley-Ann
    Dowsett, Mitch
    CANCER CELL, 2013, 24 (01) : 7 - 9
  • [30] BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?
    Symmans, F. W.
    BREAST, 2015, 24 : S12 - S12
12345